PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.51%
Negative net income growth while MRVL stands at 109.86%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.38%
Less D&A growth vs. MRVL's 5.75%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-5666.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-8.82%
Negative yoy SBC while MRVL is 13.16%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-105.20%
Negative yoy working capital usage while MRVL is 6.80%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-3.33%
AR is negative yoy while MRVL is 64.82%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-72.20%
Negative yoy inventory while MRVL is 22.96%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-19.05%
Both negative yoy AP, with MRVL at -100.68%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-11.29%
Both reduce yoy usage, with MRVL at -91.58%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-117.24%
Both negative yoy, with MRVL at -60.05%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-26.17%
Negative yoy CFO while MRVL is 30.85%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-22.41%
Negative yoy CapEx while MRVL is 40.57%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
15.14%
Purchases growth of 15.14% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
20.34%
Liquidation growth of 20.34% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-120.00%
Both yoy lines negative, with MRVL at -1062.26%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
51.40%
We have mild expansions while MRVL is negative at -229.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
214.96%
Debt repayment above 1.5x MRVL's 33.27%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-35.90%
Negative yoy issuance while MRVL is 1617.46%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
14.86%
We have some buyback growth while MRVL is negative at -158.41%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.